These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Cephalosporin antibiotics: therapeutic dimensions and future. Benner EJ Postgrad Med J; 1971 Feb; 47():Suppl:135-42. PubMed ID: 5556185 [No Abstract] [Full Text] [Related]
5. Letter: Treatment of staphylococcal endocarditis and meningitis. Raff MJ N Engl J Med; 1975 May; 292(21):1132. PubMed ID: 1128565 [No Abstract] [Full Text] [Related]
6. Cephaloridine and staphylococcal endocarditis. Rountree PM; Bullen MM Br Med J; 1967 May; 2(5548):373. PubMed ID: 6023141 [No Abstract] [Full Text] [Related]
7. Failure of cephaloridine in a case of staphylococcal endocarditis. Burgess HA; Evans RJ Br Med J; 1966 Nov; 2(5524):1244. PubMed ID: 5917838 [No Abstract] [Full Text] [Related]
9. Ceftriaxone therapy for staphylococcal osteomyelitis: a review. Guglielmo BJ; Luber AD; Paletta D; Jacobs RA Clin Infect Dis; 2000 Jan; 30(1):205-7. PubMed ID: 10619757 [TBL] [Abstract][Full Text] [Related]
10. Selection of antimicrobial therapy. Weinstein AJ Instr Course Lect; 1982; 31():14-8. PubMed ID: 7175168 [No Abstract] [Full Text] [Related]
11. Antibiotic susceptibility of bacteria most commonly isolated from bone related infections: the role of cephalosporins in antimicrobial therapy. Jones ME; Karlowsky JA; Draghi DC; Thornsberry C; Sahm DF; Nathwani D Int J Antimicrob Agents; 2004 Mar; 23(3):240-6. PubMed ID: 15164964 [TBL] [Abstract][Full Text] [Related]
12. [The effectiveness of emetine in severe bacterial infections]. Melchior E Zentralbl Chir; 1966 Oct; 91(42):1558-62. PubMed ID: 5994760 [No Abstract] [Full Text] [Related]
13. The cephalosporins. Med Lett Drugs Ther; 1976 Apr; 18(8):33-5. PubMed ID: 1264017 [No Abstract] [Full Text] [Related]
15. Valvular bacterial endocarditis in the dog. Calvert CA J Am Vet Med Assoc; 1982 May; 180(9):1080-4. PubMed ID: 7045060 [No Abstract] [Full Text] [Related]
16. [Combinations of antibiotics. Clinical aspects]. Sorice F; Ortona L; Pizzigallo E G Ital Chemioter; 1974; 21(2):139-54. PubMed ID: 4471326 [No Abstract] [Full Text] [Related]
17. Panel discussion of the treatment of serious Gram-negative infections. Fekety FR; Ohkoshi M; Geddes AM; Turck M Postgrad Med J; 1971 Feb; 47():Suppl:128-35. PubMed ID: 5556184 [No Abstract] [Full Text] [Related]
18. [For which infections is the use of antibiotic combinations today considered scientifically justified?]. Modde H Fortschr Med; 1972 Aug; 90(24):827-9. PubMed ID: 4639344 [No Abstract] [Full Text] [Related]
19. [Use of vancomycin in the treatment of severe Staphylococcus aureus infection. Description of 3 cases]. Campelli A; Mantero E; Fabbri A; Nahum M; Ferraris R; Di Noto C Minerva Med; 1984 Feb; 75(8):385-90. PubMed ID: 6709217 [TBL] [Abstract][Full Text] [Related]
20. Novel cephalosporins for the treatment of MRSA infections. Glinka TW Curr Opin Investig Drugs; 2002 Feb; 3(2):206-17. PubMed ID: 12020048 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]